Also, they introduced 25 new products during the year.Torrent Pharmas presence in Germany started with the acquisition of Heumann Pharma from Pfizer in 2004-05. The Company entered into a License ...

Learn about Torrent Pharmaceuticals Limited ... Explore more about over 8069 Pharmaceutical Companies in India through our constantly updated list. Medindia Constantly updates the database.

Shareholder Return: 3-year average, Sales Growth: 3-year Compounded Annual Growth Rate, Return On Equity: 3-year Return on Equity. The company is a favourite among analysts for its robust track ...

India's Torrent Pharma says nothing to disclose on Cipla stake buy report Shares of Torrent Pharma and Cipla were down 3.1 per cent and 0.6 per cent in afternoon trading, respectively. Cipla ...

Torrent’s revenue reached Rs ... ensuring that there will be no impact on an annual basis. A healthy product mix is expected to result in a 50-100 bps increase in margins annually.

Torrent Pharmaceuticals’ promoter is expected to sell a 2.9% share in the firm worth ₹3,000 Crore in a block auction on Wednesday. The promoter is set to issue 8.27 million shares at a ...

Torrent Pharmaceuticals Ltd share price was down by -0.51% from the previous closing price of ₹3,200.55. Who are peers of Torrent Pharmaceuticals Ltd? The peers of Torrent Pharmaceuticals Ltd ...

Shares of Torrent Pharma slipped as much as 4 percent on October 30 after a block deal worth Rs 3,238.90 crore took place in the counter with promoter Torrent Investments being the likely seller.

Torrent Pharmaceuticals on Friday said it has received a demand notice of Rs 6.32 lakh from the National Pharmaceutical Pricing Authority (NPPA). The company has received the notice from NPPA under ...

India's Torrent Pharmaceuticals reported a smaller-than-expected second-quarter profit on Friday, hurt by the shutdown of an insulin manufacturing facility.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Seamless reading experience. Save your favourite. Dr Reddy's said in a statement that it will not comment on market speculations over private equity (PE) firm Bain Capital approaching the company ...